GL1X · GenesisL1 explorer

MolNFT v1 · #60014 · protein

Structure of EPAC2 in complex with cyclic-AMP and rap

3CF6 · Rap guanine nucleotide exchange factor (gef) 4: “Structure of EPAC2 in complex with cyclic-AMP and rap”. X-ray diffraction, 2 ligands (SP1, SO4), 11 pockets (best druggability 0.77). MolNFT v1 #60014 on GenesisL1: 3D structure…

PDB
3CF6
Type
protein
Length
777 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Rap guanine nucleotide exchange factor (gef) 4; RAS-related protein rap-1B
UniProt
A2ASW3, P61224
Ligands
SP1, SO4
Pockets
11 · best druggability 0.77

Structure

x-ray diffraction · 2 distinct chains · 50% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ERap guanine nucleotide exchange factor (gef) 4protein62754% helix, 16% strandA2ASW3
RRAS-related protein rap-1Bprotein15034% helix, 22% strandP61224

Ligands and binding sites

  • SP1 · 6-(6-amino-purin-9-yl)-2-thioxo-tetrahydro-2-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol · ligand · 2 copies · chains E
  • SO4 · Sulfate ion · ion · chains R

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111700.770.7989SO4
23090.760.8842SP1
31680.600.8334empty
42170.570.7936empty
51420.490.7822empty

Interfaces

1 interface between chains.

  • E–R · 1652 Ų buried · 12 hydrogen bonds · protein-protein

Compared structures

  • 3CF6 · Structure of Epac2 in complex with cyclic-AMP and Rap · the same entry in another collection · chain E against E, TM-score 1.00
  • P61224 · AlphaFold monomer V2.0 prediction for RAS-related protein rap-1B (P61224) · a predicted model of the same protein · chain R against A, TM-score 0.88

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.